These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2097712)

  • 1. Human pharmacodynamics of beta-lactams, aminoglycosides and their combination.
    Drusano GL
    Scand J Infect Dis Suppl; 1990; 74():235-48. PubMed ID: 2097712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pharmacokinetics and pharmacodynamics: does the dose matter?
    MacGowan AP
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S238-9. PubMed ID: 11524725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia.
    Schentag JJ
    Scand J Infect Dis Suppl; 1990; 74():218-34. PubMed ID: 2097710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycosides are useful for severe respiratory tract infections.
    Craig WA; Andes D
    Semin Respir Infect; 1997 Dec; 12(4):271-7. PubMed ID: 9436954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics: relation to antimicrobial resistance.
    Rybak MJ
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S38-45; discussion S64-73. PubMed ID: 16813981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides.
    Deziel-Evans LM; Murphy JE; Job ML
    Clin Pharm; 1986 Apr; 5(4):319-24. PubMed ID: 3709080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.
    Gerber AU
    Scand J Infect Dis Suppl; 1990; 74():147-54. PubMed ID: 2097702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections.
    Li C; Du X; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2007 May; 51(5):1725-30. PubMed ID: 17307978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concept of empiric therapy with antibiotic combinations. Indications and limits.
    Klastersky J
    Am J Med; 1986 May; 80(5C):2-12. PubMed ID: 3521271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood and respiratory diffusion of antibiotics. A critical analysis of predictive parameters for clinical effectiveness].
    Fantin B
    Med Mal Infect; 2006; 36(11-12):599-613. PubMed ID: 16837154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the dose matter?
    Craig WA
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S233-7. PubMed ID: 11524724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists.
    Lodise TP; Lomaestro BM; Drusano GL;
    Pharmacotherapy; 2006 Sep; 26(9):1320-32. PubMed ID: 16945055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.